Market Alert : Can Precious Metals and Oil Hold Momentum Amid U.S. Treasury Buybacks and Ongoing U.S.-Iran Tensions?

Titomic Accelerates U.S. Expansion as New Orders, Board Strengthening and Investment Drive Strategic Transformation

Titomic Accelerates U.S. Expansion as New Orders, Board Strengthening and Investment Drive Strategic Transformation Source: Kapitales Research

Highlights:

  • Titomic secured more than AU$750,000 in new U.S. orders, strengthening its presence across aerospace, defence, space, energy and industrial markets.
  • Former Boeing executive Jim Chilton was appointed to the Board, adding extensive U.S. aerospace and defence experience.
  • The Company's 31 August 2026 half-year results reflected continued investment in U.S. production capacity, with management targeting annualised operating cash flow breakeven during 2027.

Titomic Limited (ASX: TTT) came under significant market pressure, with its shares last trading at $0.132, down 22.058%. Despite the sharp decline, a series of announcements released between 31 August and 2 September 2026 outlined important developments in the Company's commercial strategy, leadership structure and U.S. expansion plans.Titomic remains focused on advanced manufacturing solutions for aerospace, defence, energy and industrial markets, with its latest updates demonstrating a continued shift towards higher-value production and sustainment opportunities in the United States.

New U.S. Orders Build Commercial Momentum

In an announcement released on 2 September 2026, Titomic reported new purchase orders from major U.S. defence contractors and energy companies worth more than AU$750,000 in aggregate. The contracts were secured over a two-week period and covered military and commercial space, commercial and military aircraft, and oil and gas applications.The Company emphasised that the strategic value of these orders extends beyond their immediate financial contribution. Titomic is seeking to establish technical credibility with major customers and progress from initial engagements and qualification work towards repeat orders and larger production programs. This approach is particularly important as Titomic works to convert its growing sales pipeline into contracted manufacturing and sustainment work across its priority markets.

Boeing Veteran Strengthens the Board

Also on 2 September 2026, Titomic announced that experienced aerospace and defence executive Jim Chilton would join the Board of Directors, effective 15 September 2026.Chilton brings almost four decades of experience from Boeing, where he held senior leadership roles across defence, space and launch programs. His previous responsibilities included oversight of major programs involving space systems, satellite operations, missile defence and other advanced aerospace activities.

The appointment reflects Titomic's effort to align its governance and leadership capabilities with its expanding U.S. operations and planned redomicile to the United States. Chilton will take over from Dr Andreas Schwer, who is due to step down from Titomic’s Board in September 2026 after contributing to the Company for almost six years.

Half-Year Results Highlight Continued Investment

Titomic's Appendix 4D and interim financial report, dated 31 August 2026, showed that revenue from ordinary activities declined 11.1% to $4.87 million for the half-year ended 30 June 2026. The Company's loss from ordinary activities after tax widened 45.3% to $19.35 million, reflecting increased expenditure associated with its strategic expansion.

The Company said it continued investing in U.S.-based production capacity, certification progression and operational scaling to support defence-related demand. Titomic is also pursuing a transition towards recurring production and sustainment revenue streams. Revenue from contracts with customers reached $3.51 million, including $1.28 million from a U.S. defence prime, while total revenue, including other income, stood at $4.87 million.

Funding and U.S. Redomicile Remain Key Priorities

Cash and cash equivalents stood at $14.26 million as at 30 June 2026, compared with $35.77 million at 31 December 2025. The Company is pursuing a combination of non-dilutive and equity funding to support its strategic initiatives across the United States, Europe and Australia.Titomic also continues progressing its proposed U.S. redomicile, which it anticipates completing during the second half of calendar 2026, subject to shareholder and court approvals. Following the restructuring, the Company intends to pursue a U.S. securities exchange listing, subject to market conditions and regulatory requirements.

Outlook

Titomic's latest announcements portray a Company in a significant investment and transformation phase. While its financial results reflect the cost of expanding manufacturing capabilities, the new U.S. orders and strengthened Board expertise indicate continued progress towards its strategic priorities.Management expects revenue growth during the remainder of 2026, supported by production contracts, expanded sustainment work and machine sales and leasing activity. As production utilisation and operating efficiency improve, Titomic is targeting progress towards annualised operating cash flow breakeven during 2027.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au